Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hyman

Showing results (231-240 of 401) with videos related to

Pageof 41
Sort By:
Journal of Cardiothoracic Surgery|August 27, 2025
Esophageal reconstruction using a hypopharyngeal anastomosis - a single center experience with review of the literatureLauren Bougioukas, Lucio M Pereira, Matthew J Weiss, et al.
JAMA Network Open|December 1, 2025
Statewide Medicaid Expansion and Survival in Resectable Non-Small Cell Lung CancerRohin Gawdi, Shahidul Islam, Calista Sha, et al.
Radiology|May 1, 1983
Telephone transfer of nuclear cardiology studiesH D Royal, J A Parker, C H Mandell, et al.
Journal of Thoracic Disease|February 27, 2024
Robotic hiatal hernia repair without meshJohn K Sadeghi, Leo T Li, Vijay A Singh, et al.
Plos One|May 7, 2015
Constructing rigorous and broad biosurveillance networks for detecting emerging zoonotic outbreaksMac Brown, Leslie Moore, Benjamin McMahon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trialsDavid M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Oncotarget|February 17, 2015
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trialsDavid M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Cancer|February 27, 2016
Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation ProgramAlexander Drilon, Anne A Eaton, Katja Schindler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2015
Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated ToxicitiesAnne Eaton, Alexia Iasonos, Mrinal M Gounder, et al.
JCO Precision Oncology|September 11, 2020
Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid TumorsEzra Y Rosen, Alison M Schram, Robert J Young, et al.
Pageof 41

Showing results (231-240 of 401) with videos related to

Sort By:
Pageof 41
Journal of Cardiothoracic Surgery|August 27, 2025
Esophageal reconstruction using a hypopharyngeal anastomosis - a single center experience with review of the literatureLauren Bougioukas, Lucio M Pereira, Matthew J Weiss, et al.
JAMA Network Open|December 1, 2025
Statewide Medicaid Expansion and Survival in Resectable Non-Small Cell Lung CancerRohin Gawdi, Shahidul Islam, Calista Sha, et al.
Radiology|May 1, 1983
Telephone transfer of nuclear cardiology studiesH D Royal, J A Parker, C H Mandell, et al.
Journal of Thoracic Disease|February 27, 2024
Robotic hiatal hernia repair without meshJohn K Sadeghi, Leo T Li, Vijay A Singh, et al.
Plos One|May 7, 2015
Constructing rigorous and broad biosurveillance networks for detecting emerging zoonotic outbreaksMac Brown, Leslie Moore, Benjamin McMahon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trialsDavid M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Oncotarget|February 17, 2015
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trialsDavid M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Cancer|February 27, 2016
Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation ProgramAlexander Drilon, Anne A Eaton, Katja Schindler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2015
Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated ToxicitiesAnne Eaton, Alexia Iasonos, Mrinal M Gounder, et al.
JCO Precision Oncology|September 11, 2020
Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid TumorsEzra Y Rosen, Alison M Schram, Robert J Young, et al.
Pageof 41